Funding for this research was provided by:
Novartis Pharma (CFTY720DIL05T)
First Online: 12 November 2019
Compliance with Ethical Standards
: Novartis AG partially supported the study.
: Maya Golan, Karin Mausner-Fainberg, Bassima Ibrahim, Moshe Benhamou, Adi Wilf-Yarkoni, Hadar Kolb, Keren Regev, and Arnon Karni have no conflicts of interest that are directly relevant to the content of this study.
: The study was approved by the local institutional review board in Helsinki (Research No. 0584-13-TLV).
: All the participants in the study signed an informed consent form upon enrollment.